Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study


Hilde Berner Hammer 1 2, Lars Karoliussen 3, Lene Terslev 4, Espen A Haavardsholm 3, Tore K Kvien 3 2, Till Uhlig 3 2

Main idea: The ultrasound scoring system for crystal depositions was sensitive to change and showed that a treat-to-target approach with urate-lowering treatment resulted in significant reductions of all the depositions, most extensively for double contour.


Objectives: As ultrasound is sensitive for detecting crystal depositions in patients with gout, our objectives were to explore the main locations for depositions and the extent of dissolution of depositions during a treat-to-target approach with urate-lowering treatment (ULT) in patients with gout.

Methods: Patients with a recent flare of gout were consecutively included in this single-center study. All patients were assessed at baseline, 3, 6, and 12 months including bilateral ultrasound examinations of joints/tendons/entheses of hands, elbows, knees, ankles, and feet.

Results: 209 of the patients were evaluated with ultrasound at baseline (mean (SD) age 56.4 (13.8) years and disease duration 7.9 (7.7) years, 95.2% men). The serum urate levels decreased from baseline to 12 months. The first metatarsophalangeal joint was the most frequent location for all the elementary lesions and erosions.


Please enter your comment!
Please enter your name here